Hypertension, ISSN 0194-911X, 03/2014, Volume 63, Issue 3, pp. 433 - 441
Journal Article
PLoS ONE, ISSN 1932-6203, 06/2019, Volume 14, Issue 6, p. e0217931
Publications determine to a large extent the possibility to stay in academia ("publish or perish"). While some pressure to publish may incentivise high quality...
MULTIDISCIPLINARY SCIENCES | RESPONSE RATES | SCIENCE | UNIVERSITIES | PUBLISH | NEOLIBERALISM | LIFE | Services | College teachers | Medical research | Humanities | Perceptions | Pressure | Neoliberalism | Teaching | Studies | Scientific papers | Ethics | Researchers | Students | Response rates | Questionnaires | Philosophy
MULTIDISCIPLINARY SCIENCES | RESPONSE RATES | SCIENCE | UNIVERSITIES | PUBLISH | NEOLIBERALISM | LIFE | Services | College teachers | Medical research | Humanities | Perceptions | Pressure | Neoliberalism | Teaching | Studies | Scientific papers | Ethics | Researchers | Students | Response rates | Questionnaires | Philosophy
Journal Article
The Lancet, ISSN 0140-6736, 07/2016, Volume 388, Issue 10040, p. 125
Ettehad and colleagues' meta-analysis on blood pressure lowering concludes that risk reduction is proportional to the magnitude of blood pressure reduction....
Heart attacks | Cardiovascular disease | Blood pressure | Disease management
Heart attacks | Cardiovascular disease | Blood pressure | Disease management
Journal Article
Nederlands tijdschrift voor geneeskunde, ISSN 0028-2162, 02/2019, Volume 163
The attributable risk of lifestyle factors for the development of diabetes, hypertension, and related disorders is very large. To what extent this attributable...
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 2014, Volume 371, Issue 6, pp. 579 - 580
Journal Article
BMC Infectious Diseases, ISSN 1471-2334, 12/2018, Volume 18, Issue 1, pp. 708 - 8
BackgroundEffective combined antiretroviral therapy (cART) has improved life expectancy among people living with HIV-1 infection. Treated HIV-1infection...
Pulse wave velocity | Augmentation index | Metabolic syndrome | Cardiovascular risk | First-line combined antiretroviral therapy | ADULT PATIENTS | INFECTIOUS DISEASES | PULSE-WAVE VELOCITY | ATHEROSCLEROSIS | PREVALENCE | PARAMETERS | AORTIC STIFFNESS | MATRIX METALLOPROTEINASES | DISEASE RISK | THERAPY | Antiviral agents | Complications and side effects | Vascular resistance | Patient outcomes | Dosage and administration | Drug therapy, Combination | Metabolic syndrome X | Drug therapy | HIV infection | Health aspects | Risk factors | Heart | Sexually transmitted diseases--STD | Nevirapine | Medical services | Cardiovascular disease | Infections | Family medical history | Multivariate analysis | Efavirenz | Antiretroviral agents | Human immunodeficiency virus--HIV | Aorta | Stiffness | Blood pressure | Antiretroviral drugs | Medical research | Life expectancy | Diabetes mellitus | Health risks | Lamivudine | Risk analysis | Patients | Antiretroviral therapy | Heart rate | Studies | Hospitals | Life span | Sampling methods | Diabetes | Wave velocity | Cardiovascular diseases | Zidovudine | Metabolic disorders | Veins & arteries
Pulse wave velocity | Augmentation index | Metabolic syndrome | Cardiovascular risk | First-line combined antiretroviral therapy | ADULT PATIENTS | INFECTIOUS DISEASES | PULSE-WAVE VELOCITY | ATHEROSCLEROSIS | PREVALENCE | PARAMETERS | AORTIC STIFFNESS | MATRIX METALLOPROTEINASES | DISEASE RISK | THERAPY | Antiviral agents | Complications and side effects | Vascular resistance | Patient outcomes | Dosage and administration | Drug therapy, Combination | Metabolic syndrome X | Drug therapy | HIV infection | Health aspects | Risk factors | Heart | Sexually transmitted diseases--STD | Nevirapine | Medical services | Cardiovascular disease | Infections | Family medical history | Multivariate analysis | Efavirenz | Antiretroviral agents | Human immunodeficiency virus--HIV | Aorta | Stiffness | Blood pressure | Antiretroviral drugs | Medical research | Life expectancy | Diabetes mellitus | Health risks | Lamivudine | Risk analysis | Patients | Antiretroviral therapy | Heart rate | Studies | Hospitals | Life span | Sampling methods | Diabetes | Wave velocity | Cardiovascular diseases | Zidovudine | Metabolic disorders | Veins & arteries
Journal Article
7.
Full Text
Treatment of hypercholesterolaemia in older adults calls for a patient-centred approach
Heart, ISSN 1355-6037, 11/2019, p. heartjnl-2019-315600
Due to an increasing number of older adults with (risk factors for) cardiovascular disease (CVD), the sum of older adults eligible for lipid-lowering drugs...
Journal Article
NEW ENGLAND JOURNAL OF MEDICINE, ISSN 0028-4793, 12/2017, Volume 377, Issue 25, pp. 2505 - 2505
Journal Article
European Journal of Clinical Investigation, ISSN 0014-2972, 07/2019, Volume 49, Issue 7, pp. 1 - 10
Background: Recently, it was shown that 12 weeks of lipopolysaccharide (LPS) administration to nonatherosclerotic mice induced thickening of the aortic heart...
atherosclerosis | systemic inflammation | aortic valve stenosis | Clinical Biochemistry | Biochemistry | animal model | lipopolysaccharide | MEDICINE, RESEARCH & EXPERIMENTAL | COMPLEMENT | STENOSIS | ANGIOGENESIS | LESIONS | INTERSTITIAL-CELLS | PATHOGENESIS | MEDICINE, GENERAL & INTERNAL | INFLAMMATION | DISEASE | INFECTIVE ENDOCARDITIS | Phosphates | Glycosaminoglycans | Analysis | Aortic valve stenosis | Atherosclerosis | Lipids | Apolipoproteins | Mitogens | Deposits | Calcium | Stenosis | Iron | Inflammation | Injection | Hemorrhage | Heart valves | Lipopolysaccharides | Thickness | Atherogenic diet | Apolipoprotein E | Arteriosclerosis | Fibrosis | Aorta | Mice | Infiltration | Aortic valve | Thickening
atherosclerosis | systemic inflammation | aortic valve stenosis | Clinical Biochemistry | Biochemistry | animal model | lipopolysaccharide | MEDICINE, RESEARCH & EXPERIMENTAL | COMPLEMENT | STENOSIS | ANGIOGENESIS | LESIONS | INTERSTITIAL-CELLS | PATHOGENESIS | MEDICINE, GENERAL & INTERNAL | INFLAMMATION | DISEASE | INFECTIVE ENDOCARDITIS | Phosphates | Glycosaminoglycans | Analysis | Aortic valve stenosis | Atherosclerosis | Lipids | Apolipoproteins | Mitogens | Deposits | Calcium | Stenosis | Iron | Inflammation | Injection | Hemorrhage | Heart valves | Lipopolysaccharides | Thickness | Atherogenic diet | Apolipoprotein E | Arteriosclerosis | Fibrosis | Aorta | Mice | Infiltration | Aortic valve | Thickening
Journal Article
American Journal of Physiology. Heart and Circulatory Physiology, ISSN 0363-6135, 2019, Volume 317, Issue 2, pp. H364 - H374
Reduced vasodilator properties of insulin in obesity are caused by changes in perivascular adipose tissue and contribute to microvascular dysfunction in...
LEPTIN | CARDIAC & CARDIOVASCULAR SYSTEMS | PHYSIOLOGY | animal models of human disease | NITRIC-OXIDE SYNTHASE | BONE-MARROW | INVOLVEMENT | vascular biology | lifestyle | PROTECTS | inflammation | VASOREACTIVITY | RESISTANCE | FAT | PERIPHERAL VASCULAR DISEASE | EXPRESSION | obesity | Adipose tissue | Syngeneic grafts | Interleukin | Bone marrow transplantation | Fluorescence | Gene deletion | Vasodilation | Metastases | Interleukin 6 | Proteins | Clonal deletion | Ultrasonography | Bone marrow | Deletion | Stat1 protein | Obesity | Phenotypes | Myeloid cells | Cytokines | Muscles | Inflammation | Tumor necrosis factor-α | Gene expression | IL-1β | Insulin | Skeletal muscle | Musculoskeletal system | Diet | Perfusion | Green fluorescent protein | Microvasculature
LEPTIN | CARDIAC & CARDIOVASCULAR SYSTEMS | PHYSIOLOGY | animal models of human disease | NITRIC-OXIDE SYNTHASE | BONE-MARROW | INVOLVEMENT | vascular biology | lifestyle | PROTECTS | inflammation | VASOREACTIVITY | RESISTANCE | FAT | PERIPHERAL VASCULAR DISEASE | EXPRESSION | obesity | Adipose tissue | Syngeneic grafts | Interleukin | Bone marrow transplantation | Fluorescence | Gene deletion | Vasodilation | Metastases | Interleukin 6 | Proteins | Clonal deletion | Ultrasonography | Bone marrow | Deletion | Stat1 protein | Obesity | Phenotypes | Myeloid cells | Cytokines | Muscles | Inflammation | Tumor necrosis factor-α | Gene expression | IL-1β | Insulin | Skeletal muscle | Musculoskeletal system | Diet | Perfusion | Green fluorescent protein | Microvasculature
Journal Article
The Lancet, ISSN 0140-6736, 07/2016, Volume 388, Issue 10040, pp. 125 - 125
Journal Article
BMJ Open, ISSN 2044-6055, 05/2019, Volume 9, Issue 6, p. e023442
ObjectivesElectronic dance music (EDM) concerts are becoming increasingly popular. Strong stroboscopic light effects are commonly part of these shows, and may...
epilepsy | epidemiology | preventive medicine | Ecstasy | Video recordings | Studies | Convulsions & seizures | Consciousness | Epilepsy | Light | Audiences | Emergency medical care | Electroencephalography | Music festivals | Epidemiology
epilepsy | epidemiology | preventive medicine | Ecstasy | Video recordings | Studies | Convulsions & seizures | Consciousness | Epilepsy | Light | Audiences | Emergency medical care | Electroencephalography | Music festivals | Epidemiology
Journal Article
BMC infectious diseases, ISSN 1471-2334, 02/2019, Volume 19, Issue 1, pp. 187 - 1
Following publication of the original article [1], the authors reported that they have provided the wrong caption.
Journal Article
Current Pharmaceutical Design, ISSN 1381-6128, 04/2012, Volume 18, Issue 11, pp. 1502 - 1511
There is abundant evidence that rheumatoid arthritis (RA), a chronic inflammatory disorder, is associated with an increased risk for cardiovascular (CV)...
Cardiovascular disease | TNF inhibitors | Inflammation | Rheumatoid arthritis | C-REACTIVE PROTEIN | INTIMA-MEDIA THICKNESS | cardiovascular disease | SYSTEMIC-LUPUS-ERYTHEMATOSUS | IMPROVES ENDOTHELIAL FUNCTION | FACTOR-ALPHA BLOCKADE | HIGH-DENSITY-LIPOPROTEIN | inflammation | LOW BODY-MASS | INSULIN-RESISTANCE | PHARMACOLOGY & PHARMACY | TRANSMEMBRANE TNF-ALPHA | CORONARY-HEART-DISEASE | Tumor Necrosis Factor-alpha - metabolism | Cardiovascular Diseases - etiology | Cardiovascular Diseases - prevention & control | Humans | Risk Factors | Tumor Necrosis Factor-alpha - genetics | Biomarkers | Arthritis, Rheumatoid - complications | Tumor Necrosis Factor-alpha - antagonists & inhibitors
Cardiovascular disease | TNF inhibitors | Inflammation | Rheumatoid arthritis | C-REACTIVE PROTEIN | INTIMA-MEDIA THICKNESS | cardiovascular disease | SYSTEMIC-LUPUS-ERYTHEMATOSUS | IMPROVES ENDOTHELIAL FUNCTION | FACTOR-ALPHA BLOCKADE | HIGH-DENSITY-LIPOPROTEIN | inflammation | LOW BODY-MASS | INSULIN-RESISTANCE | PHARMACOLOGY & PHARMACY | TRANSMEMBRANE TNF-ALPHA | CORONARY-HEART-DISEASE | Tumor Necrosis Factor-alpha - metabolism | Cardiovascular Diseases - etiology | Cardiovascular Diseases - prevention & control | Humans | Risk Factors | Tumor Necrosis Factor-alpha - genetics | Biomarkers | Arthritis, Rheumatoid - complications | Tumor Necrosis Factor-alpha - antagonists & inhibitors
Journal Article
Nederlands tijdschrift voor geneeskunde, ISSN 0028-2162, 06/2019, Volume 163
A paraneoplastic syndrome is a phenomenon or complex of symptoms that can occur with malignancy, without this being the result of tumour cells in the affected...
Journal Article
Heart, ISSN 1355-6037, 10/2018, Volume 104, Issue 20, p. 1699
Objective In statin-treated patients with stable coronary artery disease (CAD), residual risk of cardiovascular events is partly explained by plasma levels of...
coronary artery disease | Cardiology and Cardiovascular Medicine | cardiac risk factors and prevention
coronary artery disease | Cardiology and Cardiovascular Medicine | cardiac risk factors and prevention
Journal Article
Diabetes, ISSN 0012-1797, 05/2018, Volume 67, Issue Supplement 1, p. 270
Journal Article
Nederlands tijdschrift voor geneeskunde, ISSN 0028-2162, 2015, Volume 159, p. A9322
Statins are among the most commonly prescribed drugs in the Western world. Hence, one would expect their safety and side effect profile to be firmly...
Hypolipidemic Agents - adverse effects | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Humans | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Hypolipidemic Agents - therapeutic use | Memory Disorders - chemically induced
Hypolipidemic Agents - adverse effects | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Humans | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Hypolipidemic Agents - therapeutic use | Memory Disorders - chemically induced
Journal Article
PLoS ONE, ISSN 1932-6203, 09/2016, Volume 11, Issue 9
Journal Article
Nederlands Tijdschrift voor Geneeskunde, ISSN 0028-2162, 2018, Volume 162, Issue 7
Journal Article
No results were found for your search.
Cannot display more than 1000 results, please narrow the terms of your search.